Article Text

Download PDFPDF

140 Development of first-in-class ERAP2 inhibitors to modulate the cancer immunopeptidome

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.